Management of heterotopic pregnancy with uterine aspiration and systemic two-dose methotrexate.

Authors :: Vinekar K
Achilles SL
Chen BA
Source :: Contraception [Contraception] 2021 Oct; Vol. 104 (4), pp. 444-446. Date of Electronic Publication: 2021 Jun 27.
Publication Year :: 2021
Abstract: The expected trend in serum beta-human chorionic gonadotropin (β-hCG) following treatment of an undesired heterotopic pregnancy with uterine aspiration and systemic methotrexate is not known. Thus, monitoring for treatment success is challenging. We describe an undesired heterotopic pregnancy treated with aspiration and two-dose methotrexate and report the observed β-hCG trend.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)

Subjects :: Chorionic Gonadotropin
Chorionic Gonadotropin, beta Subunit, Human
Female
Humans
Methotrexate
Pregnancy
Retrospective Studies
Uterus
Abortifacient Agents, Nonsteroidal
Pregnancy, Heterotopic diagnostic imaging
Pregnancy, Heterotopic drug therapy

Full Text Access

Tools